Work

P‐057: Validation of the xMAP technology and performance of INNO‐BIA AlzBio3 for quantification in CSF of Aβ1–42, total tau and P‐tau181p

Year: 2007

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2007.04.310

Authors: Leslie M. Shaw, Hugo Vanderstichele, Margaret Knapik-Czajka, Kaj Blennow, Holly Soares, Adam Simon, Piotr Lewczuk, Eric Siemers, Robert Dean, Nancy Raha, Derek L. Chappell, Jens Wiltfang, Richard Lachno, Brent E. Salfen, Virginia M-Y. Lee, John Q. Trojanowski

Institutions: University of Pennsylvania, Fujirebio (Belgium), Sahlgrenska University Hospital, Pfizer (United States), Merck & Co., Inc., Rahway, NJ, USA (United States), Friedrich-Alexander-Universität Erlangen-Nürnberg, Eli Lilly (United States), Austin Diagnostic Clinic, St. Charles Medical Center

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2584331727

FWCI:

Cites:

Cited by:

Related to: 10